
ViroCell Biologics
London, United Kingdomvirocell.comFrom their website, Nov 2026
- GMP
Work here? Claim this listing
About
ViroCell Biologics is a lentiviral and retroviral vector CDMO focused on design, optimization, process development, and GMP manufacturing. It serves cell and gene therapy programs, including support for clinical trials, from its facility in central London, UK.
Services
Innovation Research
Develops new manufacturing technologies and more effective and safer lentiviral and retroviral vectors.
Viral Vector Design & Optimization
Designs and optimizes lentiviral or retroviral vector candidates to refine performance evaluation and improve key attributes.
Viral Vector Process Development
Optimizes processes to improve lentiviral and retroviral vector yields and support preclinical manufacturing.
GMP Lentiviral & Retroviral Vector Manufacturing
Manufactures GMP lentiviral and retroviral vectors for clinical use.
Regulatory Submissions
Supports IND, IMPD, CTA, MHRA, FDA and EMA submissions.
- Turnaround
- <14-week turnaround times
- 6 months from plasmid to GMP batch release
- 6 months from the start of your campaign
- What to send
- Plasmid
Capabilities
- Assays and studies
- Lentivirus
- Process development
- Scale and capacity
- 12L to 50L scale
- 6,400 sq ft GMP facility
- Two full-time Qualified Persons (QPs)
- Therapeutic areas
- Cancer
- Rare monogenic disease
- Autoimmune diseases
- Cardiovascular conditions
- In vivo CAR-T therapies
Instruments and platforms
- Qualified external Quality Control (QC) release testing vendors
Modalities and species
- Modalities
- Viral vector
- Cell therapy
- Species and models
- HEK293 cell line
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Details
- Type
- CRDMO
- Founded
- 2021
- Address
- 5 New Street Square, London EC4A 3TW
- Serves
- UK
- General enquiry
- info@virocell.com on their site